Effect of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: the Japan Morning Surge-Target Organ Protection (J-TOP) study.
about
Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data and meta-analysesRationale, study design, and implementation of the ACS1 study: effect of azilsartan on circadian and sleep blood pressure as compared with amlodipine.Effect of the angiotensin II receptor antagonist olmesartan on morning home blood pressure in hypertension: HONEST study at 16 weeks.Difference in the effects of switching from candesartan to olmesartan or telmisartan to olmesartan in hypertensive patients with type 2 diabetes: the COTO studyEmerging concept of anti-hypertensive therapy based on ambulatory blood pressure profile in chronic kidney disease.Nocturnal blood pressure, morning blood pressure surge, and cerebrovascular events.Nocturnal medications dosing: does it really make a difference in blood pressure control among patients with chronic kidney disease?The dilemma of nocturnal blood pressure.Proposal of a new strategy for ambulatory blood pressure profile-based management of resistant hypertension in the era of renal denervation.The reason why home blood pressure measurements are preferred over clinic or ambulatory blood pressure in Japan.Clinical significance of home blood pressure and its possible practical application.Chronotherapeutics of conventional blood pressure-lowering medications: simple, low-cost means of improving management and treatment outcomes of hypertensive-related disorders.Sleep Blood Pressure Self-Measured at Home as a Novel Determinant of Organ Damage: Japan Morning Surge Home Blood Pressure (J-HOP) Study.Comparison of effects of angiotensin II receptor blocker on morning home blood pressure and cardiorenal protection between morning administration and evening administration in hypertensive patients: the COMPATIBLE study.Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension.The coefficient variation of home blood pressure is a novel factor associated with macroalbuminuria in type 2 diabetes mellitus.Association of home and ambulatory blood pressure changes with changes in cardiovascular biomarkers during antihypertensive treatment.Rationale and design for the Asia BP@Home study on home blood pressure control status in 12 Asian countries and regions.Dose Timing of an Angiotensin II Receptor Blocker/Calcium Channel Blocker Combination in Hypertensive Patients With Paroxysmal Atrial Fibrillation.Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks.Sleep duration and insomnia in the elderly: associations with blood pressure variability and carotid artery remodeling.Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.Visit-to-visit blood pressure variability, average BP level and carotid arterial stiffness in the elderly: a prospective study.Evolution of target organ damage by different values of self-blood pressure measurement in untreated hypertensive patients.The optimal timing of antihypertensive medication administration for morning hypertension in patients with cerebral infarction.Morning blood pressure surge: pathophysiology, clinical relevance and therapeutic aspects.
P2860
Q26996563-22723ABE-C921-427D-8E0B-AC554E67D53CQ33572346-5B9932C9-89DD-4A0B-936A-2A3541C4A354Q37317689-D7D00CFB-9280-493C-A942-8E5D2ACAE43CQ37601188-DC219C95-16D1-4577-AF22-A5DF5C90503DQ37976710-9A8FD59F-95DA-4D26-AE5B-3E78148751C6Q38005055-D5DDE39D-A475-43A8-AED1-E34C5D343193Q38029919-099435BA-155E-461A-8F8E-C3991756BBC4Q38057766-C23B3B9F-F5FC-41B6-B51B-45DD8CB87EF2Q38091561-F08C09C5-B323-4891-B638-C3BF1BB8E5CAQ38099744-F9324EF8-1230-4AF3-ACD3-229DF05537D9Q38118933-4515BF5F-C31B-4437-822B-D4A8EB2CD6F4Q38177166-44340DF8-E3A3-405F-A58D-3B2EB8A2418DQ41418908-ACE03F6D-4D89-4A99-8F70-1B9D25EB1584Q44009304-91DD9762-18DB-4B21-B74F-F139B46B1CB7Q44373377-5B43E2C4-9CBE-44AF-8EA1-B356DC20B182Q44461483-72982213-67A3-452E-A49B-3A656C3655F9Q45772264-AA301D58-5BF8-4AFF-92E8-C4BA7D14173BQ47229341-6FBEBFE1-DD83-4266-80F2-FD55E9F1C5BEQ47876193-393DD188-88DD-4938-B68E-D1E6A121EFB9Q47910182-0C46231F-EFC2-42D1-BA6B-FE798266A8B2Q48174680-FA0F1892-8837-4004-925E-02EDF9BF4B20Q48210138-D35387B0-0775-42EB-8143-224794C56A56Q48288364-919E171A-6DD3-48A2-A156-E4FC48E84F84Q51352466-506159FC-2A81-47E3-87CA-426294FC31D1Q51356422-97440980-C947-47F9-BA36-08FF989C573BQ54994750-986FE4DE-800D-4D29-9ADE-94C79966CCAC
P2860
Effect of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: the Japan Morning Surge-Target Organ Protection (J-TOP) study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Effect of dosing time of angio ...... rgan Protection (J-TOP) study.
@en
Effect of dosing time of angio ...... Surge-Target Organ Protection
@nl
type
label
Effect of dosing time of angio ...... rgan Protection (J-TOP) study.
@en
Effect of dosing time of angio ...... Surge-Target Organ Protection
@nl
prefLabel
Effect of dosing time of angio ...... rgan Protection (J-TOP) study.
@en
Effect of dosing time of angio ...... Surge-Target Organ Protection
@nl
P2093
P1476
Effect of dosing time of angio ...... rgan Protection (J-TOP) study.
@en
P2093
Joji Ishikawa
Kazuomi Kario
Kazuyuki Shimada
Motohiro Shimizu
Satoshi Hoshide
Shizukiyo Ishikawa
Yuichiro Yano
P304
P356
10.1097/HJH.0B013E3283395267
P50
P577
2010-07-01T00:00:00Z